Huennekens R Scott 4

What Happened
R. Scott Huennekens, a director of QuidelOrtho Corporation (QDEL), was granted 15,532 restricted stock units (RSUs) on June 25, 2026. The RSUs were reported as an award/acquisition at a $0 purchase price (derivative instrument); the filing shows no immediate cash paid. These units represent a future right to receive shares rather than immediately owned common stock.

Key Details

• Transaction date: 2026-06-25; reported on Form 4 filed 2026-06-29 (filed within the required two business days).
• Instrument and amount: 15,532 restricted stock units (RSUs) acquired; reported acquisition price $0.00 (award/derivative).
• Vesting: The RSUs will vest on June 25, 2027 (Footnote F2).
• What an RSU means: Each RSU represents the right to receive one share of common stock upon vesting (Footnote F1).
• Shares owned after transaction: Not specified in the provided Form 4.
• Filing timeliness: Filing date indicates the Form 4 was submitted within the SEC’s two-business-day reporting window for insider transactions.

Context
RSU grants are a common form of equity compensation for executives and directors; they do not represent immediately tradable shares until they vest and are settled. The reported award is not an open-market purchase or sale and therefore does not indicate an immediate cash outlay or sale by the director. The ultimate value to the insider will depend on QuidelOrtho’s share price at vesting.